Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair
详细信息 查看全文
- 作者：Sarah Fernandes1 ; 2 ; 3 ; 10 ; James J.H. Chong1 ; 2 ; 3 ; 4 ; 5 ; 10 ; Sharon L. Paige1 ; 2 ; 3 ; Mineo Iwata8 ; Beverly Torok-Storb8 ; Gordon Keller9 ; Hans Reinecke1 ; 2 ; 3 ; Charles E. Murry1 ; 2 ; 3 ; 6 ; 7 ; murry@uw.edu" class="auth_mail" title="E-mail the corresponding author
- 刊名：Stem Cell Reports
- 出版年：2015
- 出版时间：10 November 2015
- 年：2015
- 卷：5
- 期：5
- 页码：753-762
- 全文大小：2169 K
文摘
- •
Transplantation of hBM-MNCs can halt the negative remodeling of the infarcted heart
- •
Both hESC-derived cardiovascular progenitors and definitive cardiomyocytes improve contractility
- •
hBM-MNCs lead to greater vessel number than hESC-derived cells